Related Experiment Video

Updated: Jul 6, 2025

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

15.8K

DTX2 promotes glioma development via regulation of HLTF

Ren Li1, Yang Chen2, Biao Yang2

  • 1School of Public Health, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.

Biology Direct
|January 2, 2024
PubMed
Abstract

Insights

Human Deltex 2 (DTX2), an oncogene, drives glioma progression by downregulating HLTF. Targeting the DTX2/HLTF axis offers a potential therapeutic strategy for glioma patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Human Deltex 2 (DTX2) is an oncogenic ubiquitin E3 ligase implicated in various human cancers.
  • The specific role of DTX2 in glioma progression remained largely uncharacterized.
  • This study investigates the underlying mechanisms of DTX2 function in glioma development.

Purpose of the Study:

  • To elucidate the role of DTX2 in glioma progression.
  • To identify the molecular interactions and pathways regulated by DTX2 in glioma.
  • To evaluate DTX2 as a potential prognostic or therapeutic marker for glioma.

Main Methods:

  • Bioinformatic analysis of The Cancer Genome Atlas and Human Protein Atlas data to correlate DTX2 expression with glioma clinical characteristics.
  • Immunohistochemistry and western blotting to detect DTX2 expression in glioma tissues.
  • In vitro and in vivo experiments using lentivirus-mediated gene manipulation (knockdown and overexpression) to assess the impact of DTX2 and HLTF on glioma cell behavior, including proliferation, migration, and apoptosis.
  • Protein interaction studies using immunoprecipitation and confocal microscopy.

Main Results:

  • DTX2 expression is significantly elevated in glioma samples and correlates with poorer overall survival.
  • Silencing DTX2 inhibits glioma cell viability, colony formation, and migration, while inducing apoptosis.
  • DTX2 promotes glioma progression by downregulating HLTF protein levels through increased ubiquitination.
  • HLTF exhibits tumor-suppressive effects on glioma cell proliferation and migration.
  • Overexpression of DTX2 in U87 cells leads to increased tumor volume and weight in vivo.

Conclusions:

  • The DTX2/HLTF signaling axis represents a novel pathway critical for glioma development.
  • DTX2 acts as an oncoprotein in glioma by targeting HLTF for degradation.
  • The DTX2/HLTF axis holds potential as a prognostic biomarker and a therapeutic target for glioma.
Keywords:
DTX2GliomaHLTFUbiquitination

More Related Videos

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.1K
Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts07:52

Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts

Published on: April 26, 2018

9.0K

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K